Funding Briefs

KIDNEY DISEASE STUDY CENTERS SOUGHT The National Institute of Diabetes and Digestive and Kidney Diseases within the National Institutes of Health invites qualified institutions to become research centers for the study of kidney and urologic disorders. While clinical treatment of kidney disorders has improved in recent times, scientists still have little insight into the basic physiological mechanisms of these diseases. These new study centers are intended to attract fresh investigators to the

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share


KIDNEY DISEASE STUDY CENTERS SOUGHT

The National Institute of Diabetes and Digestive and Kidney Diseases within the National Institutes of Health invites qualified institutions to become research centers for the study of kidney and urologic disorders. While clinical treatment of kidney disorders has improved in recent times, scientists still have little insight into the basic physiological mechanisms of these diseases.

These new study centers are intended to attract fresh investigators to the field as well as explore new areas of basic research that may yield clinical applications. Eligible institutions must demonstrate relevant research capabilities and a willingness to undertake significant interdisciplinary collaborations between the basic and the clinical sciences.

NIDDKD expects to award up to six center grants in 1992 from an expected pool of $4.2 million.

The application deadline is July 16. For more information, contact Ralph L. Bain, Kidney and Urology Research Centers Program Director, Division of Kidney, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies